Papillary thyroid carcinoma with brain and lung metastases: a case report
-
By
-
Ying Zhao
-
Xiaohua Chen
-
Xin Bai
-
Shujun Guo
-
Min Gao
-
Xiaohan Liu
-
Jianming Tang
-
May 25, 2026
-
Clinical Report: Papillary Thyroid Carcinoma with Brain and Lung Metastases
Overview
{'add': 'Specify the type of surgical intervention and elaborate on initial treatment challenges.'}
Background
{'add': 'Include statistics on the incidence of brain and lung metastases in PTC.'}
Data Highlights
{'remove': 'Placeholder text; replace with actual data if available.'}
Key Findings
{'rephrase': 'Ensure findings are clearly articulated and directly supported by case details.'}
Clinical Implications
{'add': 'Highlight the imaging modalities used for surveillance.'}
Conclusion
{'add': "Reiterate the case's significance in relation to existing literature."}
Related Resources & Content
- Author(s)/Org, Source, Year -- Title
- conexiant, When Thyroid and Parathyroid Collide
- Frontiers in Oncology, 2026 -- Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis
- the pathologist, When Thyroid and Parathyroid Collide
- A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation | Journal of Neuro-Oncology | Springer Nature Link
- Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer - PubMed
- Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan - Ryutaro Onaga et al., 2025
- A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation | Journal of Neuro-Oncology | Springer Nature Link
- Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer - PubMed
- Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan - Ryutaro Onaga, Tomohiro Enokida, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Masanobu Sato, Naohiro Takeshita, Hideki Tanaka, Takao Fujisawa, Susumu Okano, Hiroshi Nishino, Makoto Ito, Makoto Tahara, 2025
